<DOC>
	<DOC>NCT02176512</DOC>
	<brief_summary>Study to demonstrate the bioequivalence of telmisartan and HCTZ administered as fixed dose combination in comparison to the single unit formulations</brief_summary>
	<brief_title>Telmisartan/Hydrochlorothiazide (HCTZ) Fixed Dose Combination Compared to Its Monocomponents in Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>Healthy subjects as determined by results of screening Signed written informed consent in accordance with GCP (Good Clinical Practice) and local legislation Age ≥ 18 and ≤ 45 years Broca ≥ 20% and ≤ + 20% Any findings of the medical examination (including blood pressure, pulse rate and ECG and laboratory value) deviating from normal and of clinical relevance Gastrointestinal, hepatic, renal, respiratory, cardiovascular, metabolic, immunological or hormonal disorders Surgery of the gastrointestinal tract (except appendectomy) Diseases of the central nervous system (such as epilepsy) or psychiatric disorders Supine blood pressure at screening of systolic ≤ 110 mmHg and diastolic ≤ 60 mmHg History of orthostatic hypotension, fainting spells or blackouts Hypersensitivity to Telmisartan and/or HCTZ and/or related classes of drugs History of allergy/hypersensitivity (including drug allergy) which is deemed relevant to the trial as judged by the investigator Use of any drugs which might influence the results of the trial (≤ 10 days prior to administration or during the trial) Participation in another trial with an investigational drug (≤ 2 months prior to administration or during the trial) Smoker (≥ 10 cigarettes or ≥ 3 cigars or ≥ 3 pipes/day) Inability to refrain from smoking on study days Known alcohol abuse Known drug abuse Blood donation (≤ 1 month prior to administration) Excessive physical activities (≤ 5 days prior to administration) For female subjects: Pregnancy Positive pregnancy test No adequate contraception Inability to maintain this adequate contraception during the whole study period Lactation period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>